MiR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Li, Jun ^a,b   Lei, Han ^a   Xu, Yong ^b   Tao, Ze Zhang ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 512 5P; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERE BINDING PROTEIN; UNCLASSIFIED DRUG; MIRN512 MICRORNA, HUMAN; TERT PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME INHIBITION; ENZYME REGULATION; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HNSCC CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; REPORTER GENE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEAD AND NECK NEOPLASMS; HUMANS; LUCIFERASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; TELOMERASE;

EID: 84942412172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135265     Document Type: Article

References (27)

1. Friedman JM, Stavas MJ, Cmelak AJ. Clinical and scientific impact of human papillomavirus on head and neck cancer. World journal of clinical oncology. 2014; 5(4):781-91. Epub 2014/10/11. doi: 10. 5306/wjco.v5.i4.781 PMID: 25302178; PubMed Central PMCID: PMCPmc4129541.
2. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. International journal of cancer Journal international du cancer. 2004; 111(5):679-92. Epub 2004/07/15. doi: 10.1002/ijc.20333 PMID: 15252836.
3. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. European journal of cancer (Oxford, England: 1990). 1997; 33(5):787-91. Epub 1997/04/01. doi: 10.1016/s0959-8049(97)00062-2 PMID: 9282118.
4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. Epub 2011/03/08. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230.
5. Osterhage JL, Friedman KL. Chromosome end maintenance by telomerase. The Journal of biological chemistry. 2009; 284(24):16061-5. Epub 2009/03/17. doi: 10.1074/jbc.R900011200 PMID: 19286666; PubMed Central PMCID: PMCPmc2713563.
6. Cong Y, Shay JW. Actions of human telomerase beyond telomeres. Cell research. 2008; 18(7):725-32. Epub 2008/06/25. doi: 10.1038/cr.2008.74 PMID: 18574498.
7. Patel MM, Parekh LJ, Jha FP, Sainger RN, Patel JB, Patel DD, et al. Clinical usefulness of telomerase activation and telomere length in head and neck cancer. Head & neck. 2002; 24(12):1060-7. Epub 2002/11/28. doi: 10.1002/hed.10169 PMID: 12454944.
8. Mabruk MJ, O'Flatharta C. Telomerase: is it the future diagnostic and prognostic tool in human cancer? Expert review of molecular diagnostics. 2005; 5(6):907-16. Epub 2005/11/01. doi: 10.1586/14737159. 5.6.907 PMID: 16255632.
9. John K, Wu J, Lee BW, Farah CS. MicroRNAs in Head and Neck Cancer. International journal of dentistry. 2013; 2013:650218. Epub 2013/11/22. doi: 10.1155/2013/650218 PMID: 24260035; PubMed Central PMCID: PMCPmc3821954.
10. Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C. miRNAs in head and neck cancer revisited. Cellular oncology (Dordrecht). 2013; 36(1):1-7. Epub 2013/01/23. doi: 10.1007/s13402-012-0122-4 PMID: 23338821.
11. Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, et al. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer science. 2008; 99(2):280-6. Epub 2008/01/19. doi: 10.1111/j.1349-7006.2007.00666.x PMID: 18201269.
12. Won YS, Jeong JS, Kim SJ, Ju MH, Lee SW. Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement. Cancer letters. 2015; 356(2 Pt B):918-28. Epub 2014/12/03. doi: 10.1016/j.canlet.2014.11.006 PMID: 25444904.
13. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic acids research. 2002; 30(10):e47. Epub 2002/05/10. PMID: 12000852; PubMed Central PMCID: PMCPmc115301.
14. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med. 2006; 12(10):1133-8. Epub 2006/10/07. doi: nm1006-1133 [pii]. doi: 10.1038/nm1006-1133 PMID: 17024208.
15. Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov. 2006; 5(7):577-84. Epub 2006/06/15. doi: nrd2081 [pii]. doi: 10.1038/nrd2081 PMID: 16773071.
16. Shay JW, Keith WN. Targeting telomerase for cancer therapeutics. Br J Cancer. 2008; 98(4):677-83. Epub 2008/01/31. doi: 6604209 [pii]. doi: 10.1038/sj.bjc.6604209 PMID: 18231105; PubMed Central PMCID: PMC2259186.
17. Tao Z, Chen S, Wu Z, Xiao B, Liu J, Hou W. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA. J Laryngol Otol. 2005; 119(2):92-6. Epub 2005/04/15. doi: 10.1258/0022215053419943 PMID: 15829059.
18. Chen SM, Tao ZZ, Hua QQ, Liu D, Chi HM, Cai Q. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors. Arch Otolaryngol Head Neck Surg. 2006; 132(2):200-5. Epub 2006/02/24. doi: 132/2/200 [pii]. doi: 10.1001/archotol.132.2.200 PMID: 16490880.
19. Chen SM, Tao ZZ, Hua QQ, Xiao BK, Xu Y, Wang Y, et al. Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors. Cancer Invest. 2007; 25(8):691-8. Epub 2007/12/07. doi: 783607177 [pii]. doi: 10.1080/07357900701561065 PMID: 18058464.
20. Akiyama M, Kawano T, Mikami-Terao Y, Agawa-Ohta M, Yamada O, Ida H, et al. Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells. Leuk Res. 2011; 35(3):416-8. Epub 2010/12/18. doi: S0145-2126(10)00531-X [pii]. doi: 10.1016/j.leukres.2010.11.002 PMID: 21163530.
21. Capraro V, Zane L, Poncet D, Perol D, Galia P, Preudhomme C, et al. Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Exp Hematol. 2011; 39 (2):195-202 e2. Epub 2010/11/09. doi: S0301-472X(10)00538-2 [pii]. doi: 10.1016/j.exphem.2010.10. 008 PMID: 21056083.
22. Mizumoto Y, Kyo S, Kiyono T, Takakura M, Nakamura M, Maida Y, et al. Activation of NF-kappaB is a novel target of KRAS-induced endometrial carcinogenesis. Clin Cancer Res. 2011; 17(6):1341-50. Epub 2011/03/18. doi: 17/6/1341 [pii]. doi: 10.1158/1078-0432.CCR-10-2291 PMID: 21411444.
23. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Current opinion in cell biology. 2009; 21(3):452-60. Epub 2009/05/20. doi: 10.1016/j.ceb.2009. 04.009 PMID: 19450959.
24. Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y, et al. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene. 2009; 28(30):2738-44. Epub 2009/06/09. doi: 10.1038/onc. 2009.140 PMID: 19503096.
25. Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, et al. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci. 2006; 97(12):1366-73. Epub 2006/10/21. doi: CAS342 [pii]. doi: 10.1111/j.1349-7006.2006.00342.x PMID: 17052260.
26. Moon DO, Kim MO, Choi YH, Lee HG, Kim ND, Kim GY. Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT. FEBS Lett. 2008; 582(23-24):3367-73. Epub 2008/09/09. doi: S0014-5793(08)00716-3 [pii]. doi: 10.1016/j.febslet.2008.08.029 PMID: 18775705.
27. Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B, et al. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int J Cancer. 2009; 125 (4):783-90. Epub 2009/04/23. doi: 10.1002/ijc.24335 PMID: 19384955.